Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Analogue 71. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel GLP-1 analogues with extended half-life via microwave solid-phase synthesis. Stable, high-purity pharmaceutical intermediates for diabetes treatment.
Advanced solid-phase fragment synthesis for GpTx-1 and Analogue 71. High purity, scalable process for Nav1.7 pain therapeutics. Cost-effective manufacturing solution.